Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060001/S059

Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Self-Expanding Carotid Stent System

Medtronic Vascular, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP060001/S059

What did the FDA decide?

FDA database record P060001/S059, dated 2026-10-16, documents a 30-Day Notice for the Protégé GPS Self-Expanding Peripheral Stent System and Protégé RX Self-Expanding Carotid Stent System. The decision field states approval for a sterilization monitoring change to reduce incubation time for the biological indicator used in external process challenge devices. The supplement type is a 30-Day Notice and the supplement reason is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier.

This record does not represent a new approval of the stent systems themselves. It is a manufacturing process notice tied to the original PMA identifier P060001. The statement reports the purpose of the change but does not provide independent proof of safety or clinical effectiveness. Specific details about the previous incubation time, the new incubation time, or the biological indicator type are absent from the supplied fields.

FDA approval order statement

approval for a sterilization monitoring change to reduce incubation time for the biological indicator used in external process challenge devices
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P060001/S059
Regulatory pathway
PMA supplement
Product code
NIM
Decision code
OK30
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

For the original device and its historical approval scope, see PMA P060001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P060001 · Original PMA

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

  2. P060001/S059 received

    Application receipt date recorded by FDA.

  3. P060001/S059 · FDA decision

    30-Day Notice

  4. P060001/S060 · Related supplement

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

Timeline entries are records held by MedtechLedger for P060001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060001

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA approvalJan 24, 2007FDA
Medtronic Vascular, Inc.PMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records